|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61F 2/91 | |
| A61L 31/16 |
| (11) | Number of the document | 1586337 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05252315.6 |
| Date of filing the European patent application | 2005-04-14 | |
| (97) | Date of publication of the European application | 2005-10-19 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 826058 | 2004-04-15 | US |
| (72) |
Falotico, Robert, US
|
| (73) |
Cordis Corporation,
14201 N.W. 60th Avenue, Miami Lakes, Florida 33014,
US
|
| (54) | The local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque |
| The local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque |